Polyenecarboxylic acid derivatives, processes for preparing them, and their use
    1.
    发明授权
    Polyenecarboxylic acid derivatives, processes for preparing them, and their use 有权
    聚烯酸衍生物,其制备方法及其应用

    公开(公告)号:US07259276B2

    公开(公告)日:2007-08-21

    申请号:US10608466

    申请日:2003-06-27

    摘要: The present invention relates to novel compounds, termed serpentemycins, of the formula (I) in which Y, R, R2, R3, R4, X, X2, X3, n, m and o are as defined in the specification, which are formed by the microorganism Actinomycetales sp. DSM 14865 during its fermentation, to chemical derivatives of the serpentemycins, to a process for preparing them, and to their use as pharmaceuticals, in particular for the treatment and prophylaxis of infectious bacterial diseases.

    摘要翻译: 本发明涉及式(I)的新的化合物,称为蛇霉素,其中Y,R,R 2,R 3,R 4, X,X 2,X 3,n,m和o如本说明书中所定义,由微生物放线菌(Spinomycetales sp。)形成。 DSM 14865在其发酵过程中,涉及蛇血霉素的化学衍生物,其制备方法及其用作药物,特别是用于治疗和预防感染性细菌性疾病。

    Streptospirole derivatives
    3.
    发明授权
    Streptospirole derivatives 有权
    链球菌衍生物

    公开(公告)号:US08765799B2

    公开(公告)日:2014-07-01

    申请号:US13056751

    申请日:2009-07-16

    CPC分类号: C07D498/10 C07D491/107

    摘要: The invention relates to streptospirole derivatives of the general formula (I), wherein R1, R2, R3, X1, X2, Y1 and Y2 are as defined herein, a process for the preparation of said compounds by fermenting the microorganism Streptomyces sp. ST 108140 (DSM 19369) and optionally derivatizing the compounds produced by said microorganism, a pharmaceutical composition comprising at least one compound of the formula (I), and the use of a compound of the formula (I) for the preparation of a medicament for the treatment and/or prophylaxis of bacterial infections.

    摘要翻译: 本发明涉及通式(I)的链霉菌素衍生物,其中R1,R2,R3,X1,X2,Y1和Y2如本文所定义,通过发酵微生物Streptomyces sp。 ST108404(DSM19369),并任选地衍生由所述微生物产生的化合物,包含至少一种式(I)化合物的药物组合物和式(I)化合物在制备药物中的应用 治疗和/或预防细菌感染。

    STREPTOSPIROLE DERIVATIVES
    5.
    发明申请

    公开(公告)号:US20110295009A1

    公开(公告)日:2011-12-01

    申请号:US13056751

    申请日:2009-07-16

    CPC分类号: C07D498/10 C07D491/107

    摘要: The invention relates to streptospirole derivatives of the general formula (I), wherein R1, R2, R3, X1, X2, Y1 and Y2 are as defined herein, a process for the preparation of said compounds by fermenting the microorganism Streptomyces sp. ST 108140 (DSM 19369) and optionally derivatizing the compounds produced by said microorganism, a pharmaceutical composition comprising at least one compound of the formula (I), and the use of a compound of the formula (I) for the preparation of a medicament for the treatment and/or prophylaxis of bacterial infections.

    摘要翻译: 本发明涉及通式(I)的链霉菌素衍生物,其中R1,R2,R3,X1,X2,Y1和Y2如本文所定义,通过发酵微生物Streptomyces sp。 ST108404(DSM19369),并任选地衍生由所述微生物产生的化合物,包含至少一种式(I)化合物的药物组合物和式(I)化合物在制备药物中的应用 治疗和/或预防细菌感染。

    Methods of using and preparing thiolutin dioxide
    8.
    发明申请
    Methods of using and preparing thiolutin dioxide 审中-公开
    使用和制备硫醇二氧化物的方法

    公开(公告)号:US20050059725A1

    公开(公告)日:2005-03-17

    申请号:US10973309

    申请日:2004-10-26

    CPC分类号: A61K31/407

    摘要: The present invention relates to the use of thiolutin dioxide and its derivatives in the manufacture of a medicament. Such medicaments are useful, for example, in the treatment of CNS disorders. The present invention also relates to a process for the production of thiolutin dioxide and its derivatives by fermentation of microorganisms, such as the microorganism Nocardiopsis species ST 100692 (DSM 13834).

    摘要翻译: 本发明涉及硫醇二氧化物及其衍生物在制备药物中的用途。 这样的药物可用于例如治疗CNS疾病。 本发明还涉及通过发酵微生物例如微生物诺卡氏菌属物种ST100692(DSM13834)来生产硫醇二氧化物及其衍生物的方法。

    Cyclipostins, process for their preparation and use thereof
    9.
    发明授权
    Cyclipostins, process for their preparation and use thereof 有权
    Cyclipostins,其制备和使用的方法

    公开(公告)号:US06756402B2

    公开(公告)日:2004-06-29

    申请号:US09886044

    申请日:2001-06-22

    IPC分类号: A61K31335

    摘要: The invention relates to compounds of formula I in which R1, R2, E, X1, X2, and X3 have the meaning as described in the specification and claims, obtained by culturing Streptomyces species HAG 004107 (DSM 13381), and their physiologically tolerable salts and chemical equivalents. The invention furthermore relates to a process for the preparation of the cyclipostins, the microorganism HAG 004107 (DSM 13381), the use of the cyclipostins and their physiologically tolerable salts and chemical equivalents as pharmaceuticals, in particular as inhibitors of lipases, and pharmaceutical preparations which contain cyclipostin or a physiologically tolerable salt or equivalent thereof.

    摘要翻译: 本发明涉及式Iin化合物,其中R 1,R 2,E,X 1,X 2和X 3具有如说明书和权利要求书中所述的含义,通过培养链霉菌种类HAG 004107(DSM 13381), 及其生理上可耐受的盐和化学当量。 本发明还涉及一种制备环肽酶,微生物HAG 004107(DSM 13381),环肽素及其生理上可耐受的盐和化学等价物作为药物,特别是作为脂肪酶抑制剂的药物制剂的方法,以及药物制剂 含有Cycipostin或生理上可耐受的盐或其等同物。

    Ustilipides, method for the production and the use thereof
    10.
    发明授权
    Ustilipides, method for the production and the use thereof 失效
    乌司他丁,其生产方法和使用方法

    公开(公告)号:US06472158B1

    公开(公告)日:2002-10-29

    申请号:US09600759

    申请日:2000-07-21

    IPC分类号: C07H1514

    CPC分类号: C07H15/04 C12P19/44

    摘要: New active agents (ustilipides) formed by the microorganism Ustilago maydis, FH 2634, DSM 11494 during fermentation. The invention also relates to a method for the production of said ustilipides and to their use as medicaments in the treatment of schizophrenia or diseases caused by dopamine metabolic dysfunction. The invention further relates to medicaments containing ustilipides and to the microorganism Ustilago maydis, FH 2634, DSM 11494.

    摘要翻译: 在发酵期间由微生物Ustilago maydis,FH 2634,DSM 11494形成的新的活性剂(ustilipides)。 本发明还涉及一种生产所述麝香草皂苷的方法及其在治疗由多巴胺代谢功能障碍引起的精神分裂症或疾病中用作药物的用途。 本发明进一步涉及含ustilipides和微生物Ustilago maydis,FH 2634,DSM 11494的药物。